You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: 8,888,745


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,888,745
Title:Applicator for inserting an implant
Abstract: The invention pertains to an applicator (1) for inserting an implant, in particular a rod-like implant (2) containing an active substance, under the skin of a human or animal, comprising a housing (3), a cannula (6) extending from the housing (3), and a handle (15) for grasping and maneuvering the applicator (1) and the cannula (6) during insertion of an implant (2). In accordance with the invention, the handle (15) extends above at least part of the length of the cannula (6). Such a handle facilitates insertion of the cannula and/or accurate positioning of the implant.
Inventor(s): Van Der Graaf; Iris Epkjen Hobo (Deventer, NL), Tak; Maurice Petrus Wilhelmus (Hengelo, NL), Schmidt; Juergen (Herten, DE), Vertegaal; Hendricus Johannes (Hengelo, NL)
Assignee: Merck Sharp & Dohme B.V. (Haarlem, NL)
Application Number:11/795,796
Patent Claim Types:
see list of patent claims
Delivery; Device;
Patent landscape, scope, and claims:

United States Patent 8,888,745: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 8,888,745, titled "Applicator for Inserting an Implant," is a significant patent in the medical device sector, particularly in the field of implantable devices. This patent, issued to various assignees, including those in the pharmaceutical and medical device industries, highlights the complexity and value of intellectual property in healthcare innovation.

Patent Overview

Invention Description

The patent describes an applicator designed for inserting an implant, specifically a rod-like implant containing an active substance, under the skin of a patient. This device is crucial for delivering medications or other therapeutic agents in a controlled manner[2].

Scope of the Patent

Claims

The patent includes multiple claims that define the scope of the invention. These claims are divided into independent and dependent claims, each detailing specific aspects of the applicator and its components.

  • Independent Claims: These claims define the broadest scope of the invention. For example, Claim 1 might describe the overall structure and function of the applicator, including its components such as the implant, the insertion mechanism, and any safety features.
  • Dependent Claims: These claims build upon the independent claims and provide additional details or specific embodiments of the invention. For instance, a dependent claim might specify the material used for the implant or the mechanism for releasing the active substance[2].

Claim Construction

The construction of claims is critical in defining the patent's scope. Each claim must be clear, concise, and supported by the patent's specification. The claims are analyzed to determine their validity and enforceability, ensuring they do not infringe on existing patents and are novel and non-obvious.

Patent Landscape

Related Patents and Prior Art

The patent landscape for implantable devices and applicators is extensive. Patents like US 8,888,745 must be distinguished from prior art to establish their novelty and non-obviousness. This involves a thorough search of existing patents, patent applications, and other relevant literature to ensure that the claimed invention is unique and innovative.

Competitors and Assignees

Companies like Merck, which have sought patents for similar medical devices and treatments, are key players in this landscape. The assignment of patents can also indicate strategic alliances or acquisitions within the industry. For example, if a company like Merck acquires or licenses this patent, it could significantly impact their market position in the field of implantable devices[5].

Economic and Strategic Value

Monetary Value

The value of a patent like US 8,888,745 can be substantial. While the exact sale price of this specific patent is not publicly disclosed, similar patents in the medical device sector can command high prices. For instance, large-scale patent deals have seen prices ranging from $38,000 to $7.7 million per document, with mean prices often exceeding $400,000 per patent document[1].

Strategic Importance

Patents in the medical device sector are crucial for companies seeking to protect their innovations and maintain a competitive edge. These patents can be used to prevent competitors from entering the market with similar products, thereby securing market share and revenue streams.

Legal Considerations

Obviousness-Type Double Patenting (ODP)

Patents like US 8,888,745 must navigate legal complexities such as ODP, which prevents an inventor from securing a second, later-expiring patent for an invention covered by a previously filed patent. This is particularly relevant in cases where multiple patents are filed as continuations or continuations-in-part, as seen in the Cellect case[4].

Patent Term Adjustment (PTA)

The patent term can be adjusted due to delays during the prosecution process. This adjustment, known as PTA, can extend the patent term but must be carefully managed to avoid issues related to ODP and terminal disclaimers[4].

Industry Impact

Innovation and R&D

Patents like US 8,888,745 drive innovation in the medical device industry by protecting intellectual property and encouraging further research and development. Companies are more likely to invest in R&D when they can secure exclusive rights to their inventions.

Market Domination

Companies that hold significant patents in this sector can dominate the market by preventing competitors from using similar technologies. This can lead to higher prices and reduced competition, but it also ensures that the innovator can recoup their investment in R&D.

Conclusion

United States Patent 8,888,745 is a valuable asset in the medical device industry, offering a unique solution for inserting implants containing active substances. Understanding its scope, claims, and the broader patent landscape is crucial for companies looking to navigate this complex and highly competitive field.

Key Takeaways

  • Patent Scope: The patent's scope is defined by its claims, which must be clear, concise, and supported by the specification.
  • Economic Value: Patents in the medical device sector can command high prices and are strategically important for market dominance.
  • Legal Considerations: Patents must navigate legal issues such as ODP and PTA to ensure their validity and enforceability.
  • Industry Impact: Patents drive innovation and can lead to market domination, but they also require significant investment in R&D.

FAQs

Q: What is the primary purpose of the applicator described in US 8,888,745?

A: The primary purpose is to insert an implant, specifically a rod-like implant containing an active substance, under the skin of a patient.

Q: How are the claims in a patent like US 8,888,745 constructed?

A: Claims are constructed to define the scope of the invention, with independent claims outlining the broadest scope and dependent claims providing additional details.

Q: What is the significance of Obviousness-Type Double Patenting (ODP) in patent law?

A: ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a previously filed patent, ensuring that patents do not extend beyond their intended term.

Q: How can patents like US 8,888,745 impact the market?

A: These patents can prevent competitors from entering the market with similar products, allowing the patent holder to secure market share and revenue streams.

Q: What is the role of Patent Term Adjustment (PTA) in patent law?

A: PTA adjusts the patent term due to delays during the prosecution process, ensuring that the patent holder receives the full term of protection despite any delays.

Sources

  1. Perpetual Motion Patents - The value of a patent.
  2. Unified Patents - US-8888745-B2 - Applicator for Inserting an Implant.
  3. USPTO - Patent Claims Research Dataset.
  4. United States Court of Appeals for the Federal Circuit - In re Cellect.
  5. IPWatchdog - Merck seeks patents on cancer treatments, medications for Alzheimer’s.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,888,745

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Organon NEXPLANON etonogestrel IMPLANT;IMPLANTATION 021529-002 May 13, 2011 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,888,745

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
05100419Jan 24, 2005
PCT Information
PCT FiledJanuary 20, 2006PCT Application Number:PCT/EP2006/050328
PCT Publication Date:July 27, 2006PCT Publication Number: WO2006/077242

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.